Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic effects of vasopressin in refractory shock after cardiac arrest
2006-005421-31Phase 3Active
- Sponsor
- RER Saint Denis
- Start
- Mar 2007
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3 trial of vasopressin in Shock and cardiac arrest (SCA), sponsored by RER Saint Denis. Primary endpoint: Decrease in vasopressor support requirement. Started Mar 2007; status: active.
02
Drugs
vasopressin
03
Conditions
Shockcardiac arrest (SCA)
Beyond the preview
Go deeper on 2006-005421-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005421-31.